Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

REMODULIN for Cor pulmonale chronic: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 220 adverse event reports in the FDA FAERS database where REMODULIN was used for Cor pulmonale chronic.

Most Reported Side Effects for REMODULIN

Side Effect Reports % Deaths Hosp.
Death 95 13.7% 93 8
Dyspnoea 79 11.4% 4 71
Device related infection 64 9.2% 1 63
Drug dose omission 42 6.0% 1 37
Nausea 32 4.6% 0 25
Headache 30 4.3% 0 18
Diarrhoea 28 4.0% 1 19
Pulmonary arterial hypertension 28 4.0% 10 20
Vomiting 28 4.0% 1 24
Fluid retention 27 3.9% 1 23
Pneumonia 27 3.9% 1 25
Hypotension 24 3.5% 3 20
Fall 23 3.3% 2 16
Infusion site pain 21 3.0% 0 10
Dizziness 20 2.9% 0 15

Other Indications for REMODULIN

Pulmonary arterial hypertension (372) Product used for unknown indication (56) Pulmonary hypertension (11)

Other Drugs Used for Cor pulmonale chronic

TREPROSTINIL (1,407) AMBRISENTAN (879) MACITENTAN (254) EPOPROSTENOL (239) BOSENTAN\BOSENTAN (238) TYVASO (143) TRACLEER (101) ILOPROST (65) BOSENTAN (60) VELETRI (43)

Related Pages

REMODULIN Full Profile All Cor pulmonale chronic Drugs REMODULIN Demographics REMODULIN Timeline